Wall Street analysts forecast Under Armour (UAA) to report Q1 EPS of $0.03, a 200% year-over-year increase, on revenues of $1.13 billion, a 4.3% decline. While the consensus EPS estimate has been stable, detailed segment projections indicate broader revenue weakness, with apparel and footwear sales expected to drop 3.6% and 7.7% respectively, and significant regional declines in North America, Asia-Pacific, and Latin America, partially offset by projected 7.7% growth in EMEA. This mixed outlook comes as UAA shares have underperformed the S&P 500 over the past month, returning -3.4% versus +1%, and the stock carries a Zacks Rank #4 (Sell), signaling potential near-term underperformance.
Under Armour (UAA) faces a mixed outlook ahead of its Q1 earnings release, characterized by a significant divergence between profitability and sales forecasts. Wall Street consensus projects a 200% year-over-year increase in earnings per share to $0.03, yet anticipates a 4.3% decline in total revenue to $1.13 billion. This top-line weakness appears broad-based, with expected revenue contractions across key product categories, including a 3.6% drop in Apparel and a more pronounced 7.7% fall in Footwear. The distribution channel breakdown reveals further concern, as Direct-to-Consumer sales are projected to decline by 6.9%, outpacing the 2.5% expected drop in the Wholesale channel. Geographically, the forecast is particularly weak for the Asia-Pacific and Latin America regions, with anticipated revenue declines of 15.5% and 10.6% respectively, alongside a 4.4% contraction in the core North American market. The only bright spot is a projected 7.7% revenue growth in the EMEA region. This challenging fundamental picture is compounded by the stock's recent market underperformance, having returned -3.4% over the past month against the S&P 500's 1% gain, and a Zacks Rank #4 (Sell), signaling potential for continued near-term weakness.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment